Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine.
Bender S, Dittmann-Balcar A, Schall U, Wolstein J, Klimke A, Riedel M, Vorbach EU, Kühn KU, Lambert M, Dittmann RW, Naber D. Bender S, et al. Among authors: riedel m. Int J Neuropsychopharmacol. 2006 Apr;9(2):135-45. doi: 10.1017/S1461145705005924. Epub 2005 Sep 21. Int J Neuropsychopharmacol. 2006. PMID: 16174427 Free article. Clinical Trial.
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Bechdolf A, Müller H, Stützer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brüne M, Krüger-Özgürdal S, Wobrock T, Riedel M, Klosterkötter J; PREVENT study group. Bechdolf A, et al. Among authors: riedel m. Schizophr Bull. 2011 Sep;37 Suppl 2(Suppl 2):S111-21. doi: 10.1093/schbul/sbr083. Schizophr Bull. 2011. PMID: 21860040 Free PMC article. Clinical Trial.
Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: riedel m. Acta Psychiatr Scand. 2010 May;121(5):359-70. doi: 10.1111/j.1600-0447.2009.01484.x. Epub 2009 Oct 30. Acta Psychiatr Scand. 2010. PMID: 19878135
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.
Schennach-Wolff R, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Jäger M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: riedel m. Eur Psychiatry. 2011 Jul-Aug;26(5):284-92. doi: 10.1016/j.eurpsy.2009.11.005. Epub 2010 May 1. Eur Psychiatry. 2011. PMID: 20435447
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Schennach-Wolff R, Möller HJ, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Riedel M. Schennach-Wolff R, et al. Among authors: riedel m. Pharmacopsychiatry. 2010 Nov;43(7):245-51. doi: 10.1055/s-0030-1262788. Epub 2010 Oct 6. Pharmacopsychiatry. 2010. PMID: 20927697
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
Jäger M, Riedel M, Obermeier M, Schennach-Wolff R, Seemüller F, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, Gastpar M, Bottlender R, Möller HJ. Jäger M, et al. Among authors: riedel m. Schizophr Res. 2010 May;118(1-3):183-8. doi: 10.1016/j.schres.2010.02.002. Epub 2010 Feb 23. Schizophr Res. 2010. PMID: 20181461
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.
Schennach-Wolff R, Obermeier M, Seemüller F, Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach-Wolff R, et al. Among authors: riedel m. Acta Psychiatr Scand. 2011 Mar;123(3):228-38. doi: 10.1111/j.1600-0447.2010.01608.x. Epub 2010 Oct 4. Acta Psychiatr Scand. 2011. PMID: 21029053
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study.
Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Degner D, Buchkremer G, Gastpar M, Möller HJ, Riedel M. Jäger M, et al. Among authors: riedel m. Eur Psychiatry. 2009 Dec;24(8):501-6. doi: 10.1016/j.eurpsy.2009.02.005. Epub 2009 Jun 25. Eur Psychiatry. 2009. PMID: 19559572
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.
Schennach R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Schennach R, et al. Among authors: riedel m. Eur Psychiatry. 2012 Nov;27(8):625-33. doi: 10.1016/j.eurpsy.2012.01.001. Epub 2012 Apr 28. Eur Psychiatry. 2012. PMID: 22542652
617 results